Information Provided By:
Fly News Breaks for September 22, 2017
ZBH, SYK
Sep 22, 2017 | 07:40 EDT
RBC Capital analyst Glenn Novarro says that Stryker " will be the biggest share gainer in knees given its momentum in cementless and robotics." The analyst thinks that it will benefit in the near-term from Zimmer Biomet's (ZBH) supply issues. He recommends that growth investors buy Stryker.
News For SYK;ZBH From the Last 2 Days
There are no results for your query SYK;ZBH